Tuesday, July 26, 2016

GlaxoSmithKline invests $360 mln in post-Brexit UK manufacturing

LONDON, July 27 (Reuters) - GlaxoSmithKline plans

275 million pounds ($361 million) of new investments at three

drug manufacturing sites in Britain, signalling its confidence

in the country despite...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)